Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Growing up with a heart disease, Ashley Pecora never knew what her life was going to look like—until two years ago when she ...

The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

Heart disease remains the leading cause of death in the United States, claiming approximately 700,000 lives each year.

Beyond surgical excellence, St. Elizabeth prioritizes a highly specialized and patient-focused approach to cardiac care.